Asperger syndrome cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD [2]

Overview

Based on a prevalence of 1.1 % for autism spectrum disorder (ASD) in the US, the economic burden for ASD has been estimated to be $268.2991 billion (1.467% of GDP) and $460.8002 billion (1.649% of GDP) in 2015 and 2025 respectively.^[1]

Cost-Effectiveness of Therapy

Based on a prevalence of 1.1 % for autism spectrum disorder (ASD) in the US, the economic burden for ASD has been estimated to be $268.2991 billion (1.467% of GDP) and $460.8002 billion (1.649% of GDP) in 2015 and 2025 respectively.^[1]

References

↑ ^1.0 ^1.1 Leigh JP, Du J (2015). “Brief Report: Forecasting the Economic Burden of Autism in 2015 and 2025 in the United States”. J Autism Dev Disord. 45 (12): 4135–9. doi:10.1007/s10803-015-2521-7. PMID 26183723.

[pmid26183723-1] 1.0 ^1.1 Leigh JP, Du J (2015). “Brief Report: Forecasting the Economic Burden of Autism in 2015 and 2025 in the United States”. J Autism Dev Disord. 45 (12): 4135–9. doi:10.1007/s10803-015-2521-7. PMID 26183723.

[1]